1. Home
  2. FBDT vs XLO Comparison

FBDT vs XLO Comparison

Compare FBDT & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Breach Inc. Common Stock

FBDT

First Breach Inc. Common Stock

N/A

Current Price

$0.94

Market Cap

48.4M

Sector

Industrials

ML Signal

N/A

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$8.19

Market Cap

56.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FBDT
XLO
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.4M
56.9M
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
FBDT
XLO
Price
$0.94
$8.19
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $18.00
AVG Volume (30 Days)
★ 259.2K
13.1K
Earning Date
11-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $43,766,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$23.90
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 589.88
52 Week Low
$0.61
$0.46
52 Week High
$1.25
$24.64

Technical Indicators

Market Signals
Indicator
FBDT
XLO
Relative Strength Index (RSI) 55.90 43.24
Support Level $0.86 $7.37
Resistance Level $1.25 $9.21
Average True Range (ATR) 0.09 0.66
MACD 0.01 -0.06
Stochastic Oscillator 69.10 44.59

Price Performance

Historical Comparison
FBDT
XLO

About FBDT First Breach Inc. Common Stock

First Breach Inc is an American defense technologies company focused on manufacturing match-grade ammunition components, finished ammunition, and developing unmanned aerial systems for commercial, law enforcement, and military markets. Its ammunition operations include the in-house production of brass cups, casings, projectiles, lead cores, lead wire, and completed ammunition. The company is also developing U.S.-made unmanned aerial systems incorporating robotics, intelligence, surveillance and reconnaissance (ISR), sensor, and precision manufacturing technologies for defense, homeland security, law enforcement, and commercial applications.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: